Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients with Plexiform Neurofibromas

2013 ◽  
Author(s):  
Kent Robertson ◽  
Melissa Lee
Keyword(s):  
Pilot Study ◽  
Imatinib Mesylate ◽  
Plexiform Neurofibromas ◽  
Sti 571

Phase II pilot study of imatinib mesylate in neurofibromatosis (NF1) patients with plexiform neurofibromas.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 10030-10030 ◽  
Author(s):  
K. A. Robertson ◽  
D. C. Bowers ◽  
F. Yang ◽  
T. Vik ◽  
C. Ho ◽  
...  
Keyword(s):  
Pilot Study ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Plexiform Neurofibromas

scholarly journals Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients

Rheumatology ◽  
2006 ◽  
Vol 45 (12) ◽  
pp. 1573-1575 ◽  
Author(s):  
K. K. Eklund ◽  
A. Remitz ◽  
H. Kautiainen ◽  
S. Reitamo ◽  
M. Leirisalo-Repo
Keyword(s):  
Pilot Study ◽  
Imatinib Mesylate ◽  
Open Label

Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7528-7528 ◽  
Author(s):  
O. Eton ◽  
L. Billings ◽  
K. Kim ◽  
V. Prieto ◽  
D. Davis ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Sti 571

scholarly journals A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2

2004 ◽  
Vol 279 (33) ◽  
pp. 34227-34239 ◽  
Author(s):  
Yun Dai ◽  
Mohamed Rahmani ◽  
Seth J. Corey ◽  
Paul Dent ◽  
Steven Grant
Keyword(s):  
Imatinib Mesylate ◽  
Altered Expression ◽  
Sti 571 ◽  
Dependent Form

scholarly journals Lam Pilot Study with Imatinib Mesylate (LAMP-1): Safety and Efficacy

2020 ◽  
Author(s):  
J.M. D'Armiento ◽  
K. Foil ◽  
L. Fonseca ◽  
G. Blanton ◽  
D. Woodford ◽  
...  
Keyword(s):  
Pilot Study ◽  
Imatinib Mesylate ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document